The Precision Peptide Company Inc. Announces Extension of Investor Relations Agreement with Emerging Markets Consulting, LLC

About this update from Precision Peptide Company Inc

Vancouver, British Columbia--(Newsfile Corp. - June 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC"), is pleased to announce that, further to its news release dated October 15, 2025, it has extended its existing agreement with Emerging Markets Consulting, LLC ("EMC") for the continued provision of investor relations and communication services by EMC for an additional six month term. Emerging Markets Consulting, LLC Based in Orlando, Florida, EMC brings multiple decades of combined experience in the investor relations industry. EMC is an international investor relations firm with affiliates around the world. EMC is relationship-driven and results-oriented with the goal of seeking attractive emerging companies and concentrating on its resources and efforts to serve a limited number of high-quality clients. The extension of the engagement of EMC is for an additional six-month term commencing June 8, 2026, in consideration for a fee of USD $150,000. No company stock options were issued or will be issued to EMC. EMC's promotional activities will continue to include design, development, and dissemination services for the Company. EMC and its principals are arm's length from the Company. The contact information for EMC is: James PainterEmerging Markets Consulting, LLCAddress: LLC, 390 North Orange Avenue Suite 2300, Orlando, FL 32801. Phone: +1-407-340-0226.Email: [email protected] Website: www.emergingmarketsconsulting.com About The Precision Peptide Company The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) is a publicly traded wellness company building a next-generation platform for high-quality peptide formulations. By combining scientific formulation and innovative delivery technologies, the Company creates products at the intersection of biotechnology and scalable consumer wellness. Products are manufactured in an approved U.S. facility and distributed across North America. For more information, visit: www.precisionpeptidecompany.com. Company ContactPratap Sandhu CEO, Corporate Secretary and [email protected]+1 (604) 765-8069 Cautionary Note Regarding Forward-Looking Information This news release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These s...

View stock analysis, news, and events for Precision Peptide Company Inc